TEPEZZA® (teprotumumab) Approved in Brazil for the Treatment of Active Thyroid Eye Disease (TED)

-- First and only medicine approved in Brazil for the treatment of active TED, a…

TXOne Networks wins SC Awards Europe 2023 for ‘Newcomer of the Year’ with the OT Zero Trust concept

Industrial customers can safeguard critical infrastructures with TXOne Networks’ award-winning OT Zero Trust approach IRVING,…

TIGR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UP Fintech Holding Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of publicly…

SEMIFIVE announces commercialization of its 5nm HPC SoC Platform with lead partner Rebellions, AI Chipmaker startup based in Korea

Delivered Rebellions’ ATOMTM high performance versatile inference custom SoC built on Samsung Foundry’s leading 5nm…

Vertex Ventures HC Announces $200 Million Fund III to Drive Innovation in Healthcare

SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Vertex Ventures HC (VVHC), a women-led global healthcare investment firm, is…

Vinomofo Goes Headless with BigCommerce to Innovate, Scale and Grow its Brand Worldwide

Breadth of APIs, continuous product updates, best-in-breed partner ecosystem, strong customer base and easy integration…

NICE Actimize Named Category Winner for Suitability in WealthBriefingAsia Awards for Third Consecutive Year

NICE Actimize prioritized its investments in suitability throughout Asia, applying cloud, artificial intelligence, and advanced…

Shionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.

Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials,…